Detalhe da pesquisa
1.
Generating and using real-world data: A worthwhile uphill battle.
Cell
; 187(7): 1636-1650, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552611
2.
The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs.
Nature
; 574(7776): 127-131, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570881
3.
Managing unsolicited findings in genomics: A qualitative interview study with cancer patients.
Psychooncology
; 27(4): 1327-1333, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29471587
4.
Molecular Tumor Boards: current practice and future needs.
Ann Oncol
; 28(12): 3070-3075, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045504
5.
The time to progression ratio: a new individualized volumetric parameter for the early detection of clinical benefit of targeted therapies.
Ann Oncol
; 27(8): 1638-43, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27234642
6.
Phase I and pharmacological study of pazopanib in combination with oral topotecan in patients with advanced solid tumours.
Br J Cancer
; 113(5): 706-15, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26291057
7.
Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.
Ann Surg Oncol
; 22(5): 1555-63, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564156
8.
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours.
Br J Cancer
; 110(10): 2441-9, 2014 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24736581
9.
When is off-label off-road?
Ann Oncol
; 30(10): 1536-1538, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31688929
10.
When is off-label off-road?
Ann Oncol
; 30(12): 2018, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31893487
11.
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.
Ann Oncol
; 25(6): 1222-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608201
12.
Personalised reimbursement: a risk-sharing model for biomarker-driven treatment of rare subgroups of cancer patients.
Ann Oncol
; 30(5): 663-665, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31038154
13.
Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors.
Invest New Drugs
; 31(4): 959-66, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23345000
14.
Single-arm trials supporting the approval of anticancer medicinal products in the European Union: contextualization of trial results and observed clinical benefit.
ESMO Open
; 8(2): 101209, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37054504
15.
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression.
Br J Cancer
; 106(12): 1901-6, 2012 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22596239
16.
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin.
Br J Cancer
; 107(7): 1025-30, 2012 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910320
17.
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature.
Cancer Chemother Pharmacol
; 90(1): 97-104, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598186
18.
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
ESMO Open
; 7(6): 100611, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463731
19.
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer.
Eur J Cancer
; 171: 114-123, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716537
20.
A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer.
Br J Cancer
; 104(12): 1913-9, 2011 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21587256